Beneficient Closes $1.91 Million Financing for Mendoza Ventures Growth Fund III, LP

Beneficient announces $1.91 million financing for Mendoza Ventures Growth Fund III, enhancing its GP Primary Commitment Program.

Quiver AI Summary

Beneficient, a technology-enabled platform providing capital solutions and trust services for alternative asset holders, announced the closing of a $1.91 million primary capital commitment for Mendoza Ventures Growth Fund III, LP. This transaction marks Beneficient's third GP primary transaction this fiscal year, as the company focuses on funding opportunities that drive innovation in technology. In exchange for their investment, Mendoza Ventures received shares of Beneficient's Resettable Convertible Preferred Stock, which can be converted into common stock. The transaction is expected to enhance Beneficient's ExAlt loan portfolio and includes a new agreement to facilitate ongoing liquidity for the Fund. Beneficient aims to provide valuable capital solutions to general partners and fulfill a considerable demand for primary commitments in the fundraising ecosystem.

Potential Positives

• Beneficient has successfully closed a $1.91 million primary capital commitment for Mendoza Ventures Growth Fund III, indicating strong operational performance and growth momentum.
• This transaction marks the third GP Primary transaction for Beneficient in the fiscal year and the fourth since launching the program, showcasing the company's commitment to expanding its investment initiatives.
• The increase of approximately $1.91 million in collateral for the Company's ExAlt loan portfolio enhances its financial stability and asset base.
• Beneficient’s Preferred Liquidity Provider Program Agreement with the Fund facilitates ongoing liquidity solutions, which could strengthen relationships with clients and enhance market position.

Potential Negatives

• Company is seeking stockholder approval for the issuance of Class A common stock, indicating potential uncertainty regarding investor confidence or the desirability of the Preferred Stock.
• Press release includes a significant amount of forward-looking statements, which may suggest a lack of certainty about future performance and actual outcomes.
• The reliance on proxy statements and regulatory filings could reflect potential corporate governance issues or challenges in securing necessary approvals from stockholders.

FAQ

What is Beneficient's latest financing announcement?

Beneficient announced a $1.91 million primary capital commitment for Mendoza Ventures Growth Fund III, LP to support alternative assets.

How does Beneficient support general partners?

Beneficient provides primary capital solutions and financing anchor commitments to general partners during their fundraising efforts through its GP Primary Commitment Program.

What is the purpose of the Preferred Liquidity Provider Program Agreement?

The agreement allows Beneficient to facilitate ongoing liquidity solutions for Mendoza Ventures and its limited partners.

How does Beneficient's AltAccess platform work?

AltAccess provides users with exit options and proposals for alternative asset investments in a secure online environment.

Where can I find more information about Beneficient?

More information about Beneficient is available at www.trustben.com or their LinkedIn page.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$BENF Insider Trading Activity

$BENF insiders have traded $BENF stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $BENF stock by insiders over the last 6 months:

• JEFF WELDAY (See Remarks) has made 0 purchases and 20 sales selling 11,015 shares for an estimated $6,112.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BENF Hedge Fund Activity

We have seen 8 institutional investors add shares of $BENF stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• STIFEL FINANCIAL CORP added 72,400 shares (+99.9%) to their portfolio in Q1 2025, for an estimated $22,632
• AUSDAL FINANCIAL PARTNERS, INC. added 59,500 shares (+93.9%) to their portfolio in Q1 2025, for an estimated $18,599
• UBS GROUP AG removed 54,341 shares (-75.4%) from their portfolio in Q1 2025, for an estimated $16,986
• JANE STREET GROUP, LLC removed 52,307 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $16,351
• VIRTU FINANCIAL LLC removed 37,904 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $11,848
• TWO SIGMA SECURITIES, LLC added 37,217 shares (+inf%) to their portfolio in Q1 2025, for an estimated $11,634
• GEODE CAPITAL MANAGEMENT, LLC added 36,183 shares (+148.5%) to their portfolio in Q1 2025, for an estimated $11,310

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced it has closed on the financing of a $1.91 million primary capital commitment for Mendoza Ventures Growth Fund III, LP (“Fund”), a fund managed by Mendoza Ventures Growth GP III, L.L.C., LP (“Fund Manager”), an asset manager focused on investing in technology companies where there is an opportunity for innovation, modernization, and disruption.

The transaction represents Ben’s third GP Primary transaction of the fiscal year and fourth since formally launching the program in late 2024. In exchange for an interest in the Fund, the Fund received approximately $1.91 million in stated value of shares of the Company’s Resettable Convertible Preferred Stock (the “Preferred Stock”), which is convertible at the election of the holder into shares of the Company’s Class A common stock, subject to the terms and conditions of the transaction documents. As a result of the transaction, the collateral for the Company’s ExAlt loan portfolio is expected to increase by approximately $1.91 million of interests in alternative assets. Concurrently, the Company also entered into a Preferred Liquidity Provider Program Agreement with the Fund, whereby the Company may facilitate ongoing liquidity solutions for the Fund and its limited partners.

“We are excited to continue recent momentum by completing another GP primary capital transaction, our second transaction with a fund managed by the Fund Manager,” said Beneficient management. “We will continue to pursue additional opportunities that align with our strategic vision and growth objectives.”

Beneficient’s GP Primary Commitment Program is focused on providing primary capital solutions and financing anchor commitments to general partners during their fundraising efforts while immediately deploying capital into our equity. Through the program, Beneficient seeks to help satisfy the up to $330 billion of potential demand for primary commitments to meet fundraising needs.

About Beneficient



Beneficient (Nasdaq: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds− with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote® tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.


Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas’ Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.

For more information, visit

www.trustben.com

or follow us on

LinkedIn

.

Contacts



Matt Kreps: 214-597-8200, mkreps@darrowir.com


Michael Wetherington: 214-284-1199, mwetherington@darrowir.com


Investor Relations:

investors@beneficient.com

Important Information and Where You Can Find It



This press release may be deemed to be solicitation material in respect of a vote of stockholders to approve the issuance of the Company’s Class A common stock upon conversion of the Preferred Stock (the “Transactions”). In connection with the requisite stockholder approval, Ben will file with the Securities and Exchange Commission (the “SEC”) a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of Ben, seeking such approvals related to the Transactions.

INVESTORS AND SECURITY HOLDERS OF BEN AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTIONS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT BEN AND THE TRANSACTIONS. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about Ben, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by Ben can also be obtained, without charge, by directing a request to Investor Relations, Beneficient, 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201, or email investors@beneficient.com.

Participants in the Solicitation of Proxies in Connection with Transactions



Ben and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding Ben’s directors and executive officers is available in its annual report on Form 10-K for the fiscal year ended March 31, 2024, which was filed with the SEC on July 9, 2024 and certain current reports on Form 8-K filed by Ben. Other information regarding the participants in the solicitation of proxies with respect to the Transactions and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.

Not an Offer of Securities



The information in this communication is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the Transactions have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Forward Looking Statements



Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the Transactions. The words ”anticipate,” "believe,” ”continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” ”plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.

Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others: the ultimate outcome of the Transactions, including obtaining the requisite vote of securityholders, and the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.